NEWS RELEASES

West Island Receives Cannabis 2.0 Licence

October 25, 2022 – Dorval, Quebec – West Island Brands Inc. (WIB – CSE) (39N0 – Frankfurt) (WIBFF – OTC) (“West Island” or the “Company”) is pleased to report that subsidiary RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture (“West Island”) has received...

read more

West Island Makes First Delivery To SQDC

June 28, 2022 – Dorval, Quebec – West Island Brands Inc. (WIB – CSE) (39N0 – Frankfurt) (WIBFF – OTC) (“West Island” or the “Company”) is pleased to announce that further to our news release of January 17, 2022, West Island’s subsidiary, RoyalMax Biotechnology Canada...

read more

West Island Hits Revenue Milestone

 April 5, 2022 – Toronto, Ontario – West Island Brands Inc. (WIB – CSE) (39N0 – Frankfurt) (WIBFF – OTC) (“West Island” or the “Company”) is pleased to announce that West Island subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture has reached a...

read more

West Island Makes Cannabis 2.0 Application

March  08, 2022 – Toronto, Ontario – West Island Brands Inc. (WIB – CSE) (39N0 – Frankfurt) (WIBFF – OTCQB) (“West Island” or the “Company”) is pleased to announce the Company’s subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture (“West Island”)...

read more

West Island to Begin Sales in Quebec (English)

January 17, 2022 – Toronto, Ontario – West Island Brands Inc. (WIB – CSE) (39N0 – Frankfurt) (WIBFF – OTC) (“West Island” or the “Company”) is pleased to announce that the Company’s subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture (“West...

read more

West Island Approved for Two New SKU’s in Ontario

December 21, 2021 – Toronto, Ontario – West Island Brands Inc. (WIB – CSE) (39N0 – Frankfurt) (WIBFF – OTC) (“West Island” or the “Company”) is pleased to announce that following the tremendous success of the Sweet Demon launch under the Limited Release program, West...

read more

West Island Moves First Shipment of Cannabis to Ontario

November 9, 2021 – Toronto, Ontario – West Island Brands Inc. (WIB - CSE) (39N0 – Frankfurt) (MMJFD – OTC) (“West Island” or the “Company”) is pleased to announce that West Island subsidiary RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture has forwarded...

read more

Matica Introduces New Cannabis Brand

May 14, 2021 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) and Matica subsidiary, West Island Culture Inc. (“West Island”) are pleased to introduce our newest cannabis brand to the market CITOYENTM...

read more

Matica Partners With Green Gold To Increase Capacity

April 27, 2021 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica subsidiary RoyalMax Biotechnology Canada Inc. (“RoyalMax”) DBA West Island Culture, has entered into...

read more

Matica Forwards First Shipment of Cannabis to BC

March 16, 2021 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica subsidiary RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has forwarded its first shipment of...

read more

Matica Forwards First Shipment of Cannabis to Saskatchewan

February 3, 2021 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”), has forwarded its first shipment of...

read more

Matica Introduces Canada’s Newest Cannabis Brand

January 11, 2021 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) and Matica subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”) are pleased to introduce our exciting new cannabis brand...

read more

Matica Forwards First Shipment of Cannabis to Manitoba

January 6, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica subsidiary RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has forwarded its first shipment of...

read more

Matica Increases Ownership of Subsidiary

November 16, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) wishes to announce that Matica and its subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”), have reached an agreement...

read more

Matica Announces Sales Approval In Saskatchewan

November 2, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica subsidiary RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has received approval to supply cannabis...

read more

Royalmax Licensing Update

August 14, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that its subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”), has been informed by Health Canada that...

read more

Matica Subsidiary Receives Sales Licence

February 24, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that its subsidiary, RoyalMax Biotechnology Canada Inc. (“RoyalMax”), has received both the Standard...

read more

Matica’s Interest in RoyalMax Released

February 11, 2020 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to announce that Matica has closed the RoyalMax Biotechnology Canada Inc. (“RoyalMax”) acquisition and formally taken its...

read more

Matica Welcomes Roop Mundi to the Board

December 18, 2019 – Toronto, Ontario – Matica Enterprises Inc. (MMJ - CSE) (39N – Frankfurt) (MMJFF – OTC) (“Matica” or the “Company”) is pleased to welcome Mr. Roop Mundi to the board of directors of the Company, subject to regulatory approval.  As a former...

read more